Plain-English translation of NCT07160322 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our COPD research guide →This research study is following people with COPD who continue to struggle with shortness of breath even after taking the standard two-inhaler combination therapy (LABA/LAMA) for at least three months. Researchers want to understand why some people don't get better with this medication and what factors predict who will have the hardest time. By collecting information about your breathing, lung function, exercise ability, and blood markers over time, the study aims to identify ways to personalize treatment and improve outcomes for people like you.
Many people with COPD still feel very short of breath even when taking the best available inhaler medications. Doctors need to better understand what causes this persistent breathlessness so they can develop more targeted, personalized treatment plans that actually work for each patient.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic at the start of the study and then be followed over time. At each visit, you'll have breathing tests, walk tests to measure exercise capacity, heart imaging (echocardiogram), chest X-rays or CT scans, and blood work to check for inflammation and heart markers. Researchers will also ask about your symptoms, how much you're using your inhalers, and how your breathing is affecting your daily life. The study is observational, meaning researchers are watching and recording how you do on your current medication—they're not asking you to start anything new, but rather helping understand why some people continue to struggle despite treatment.
AI-generated summary from trial data · Jun 8, 2026 · Not medical advice
South Korea